Eric Therrien

Title: Eric Therrien: Innovator in Pharmaceutical Research

Introduction

Eric Therrien is a notable inventor based in the Bronx, NY, with a significant contribution to the field of pharmaceutical research. He holds a total of 8 patents, showcasing his innovative approach to developing new compounds and methods for treating various disorders.

Latest Patents

Among his latest patents are the SHP2 phosphatase inhibitors and methods of use thereof. This patent relates to novel compounds, including specific formulas, and pharmaceutical compositions designed to inhibit the activity of SHP2 phosphatase. The disclosure also includes methods for treating disorders associated with SHP2 deregulation, utilizing the compounds and compositions developed by Therrien.

Career Highlights

Eric Therrien has worked with prominent companies in the pharmaceutical industry, including Relay Therapeutics, Inc. and D.E. Shaw Research, LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Therrien has collaborated with esteemed colleagues such as Alexander M. Taylor and W. Patrick Walters. These partnerships have further enhanced his research capabilities and led to significant advancements in his field.

Conclusion

Eric Therrien's contributions to pharmaceutical research and his innovative patents position him as a key figure in the industry. His work continues to impact the development of treatments for disorders linked to SHP2 deregulation.